Acadian Asset Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-126,978
| Closed | -$1.36M | – | 1963 |
|
|
2022
Q3 | $1.36M | Hold |
126,978
| – | – | 0.01% | 724 |
|
|
2022
Q2 | $1.52M | Buy |
126,978
+10,500
| +9% | +$126K | 0.01% | 703 |
|
|
2022
Q1 | $2.49M | Buy |
116,478
+44,562
| +62% | +$954K | 0.01% | 618 |
|
|
2021
Q4 | $2.42M | Buy |
71,916
+7,475
| +12% | +$251K | 0.01% | 612 |
|
|
2021
Q3 | $1.66M | Buy |
64,441
+8,015
| +14% | +$206K | 0.01% | 726 |
|
|
2021
Q2 | $755K | Sell |
56,426
-3,405
| -6% | -$45.6K | ﹤0.01% | 1011 |
|
|
2021
Q1 | $635K | Sell |
59,831
-1,009
| -2% | -$10.7K | ﹤0.01% | 1109 |
|
|
2020
Q4 | $489K | Sell |
60,840
-1,208
| -2% | -$9.71K | ﹤0.01% | 1239 |
|
|
2020
Q3 | $464K | Buy |
62,048
+29,527
| +91% | +$221K | ﹤0.01% | 1154 |
|
|
2020
Q2 | $293K | Buy |
32,521
+24,393
| +300% | +$220K | ﹤0.01% | 1366 |
|
|
2020
Q1 | $79K | Buy |
8,128
+6,622
| +440% | +$64.4K | ﹤0.01% | 1401 |
|
|
2019
Q4 | $21K | Buy |
+1,506
| New | +$21K | ﹤0.01% | 1720 |
|
|
2018
Q4 | – | Sell |
-2,470
| Closed | -$44K | – | 1875 |
|
|
2018
Q3 | $44K | Sell |
2,470
-3,948
| -62% | -$70.3K | ﹤0.01% | 1396 |
|
|
2018
Q2 | $92K | Sell |
6,418
-3,699
| -37% | -$53K | ﹤0.01% | 1261 |
|
|
2018
Q1 | $194K | Buy |
10,117
+2,540
| +34% | +$48.7K | ﹤0.01% | 1068 |
|
|
2017
Q4 | $174K | Buy |
+7,577
| New | +$174K | ﹤0.01% | 985 |
|